D A Bellnier - JoVE Visualize

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

Photochemistry and Photobiology|November 24, 1999

Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.

Cancer Research|October 27, 1997

An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyB W Henderson, D A Bellnier, W R Greco, et al.

Photochemistry and Photobiology|November 1, 1995

The validation of a new vascular damage assay for photodynamic therapy agentsD A Bellnier, W R Potter, L A Vaughan, et al.

Photochemistry and Photobiology|July 1, 1996

Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacyR K Pandey, A B Sumlin, S Constantine, et al.

Journal of Medicinal Chemistry|May 4, 2001

Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1'-alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicityG Zheng, W R Potter, S H Camacho, et al.

AIDS (London, England)|October 6, 1999

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcomaZ P Bernstein, B D Wilson, A R Oseroff, et al.

Cancer Research|February 17, 2000

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateB W Henderson, T M Busch, L A Vaughan, et al.

Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

Photochemistry and Photobiology|November 24, 1999

Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.

Cancer Research|October 27, 1997

An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyB W Henderson, D A Bellnier, W R Greco, et al.

Photochemistry and Photobiology|November 1, 1995

The validation of a new vascular damage assay for photodynamic therapy agentsD A Bellnier, W R Potter, L A Vaughan, et al.

Photochemistry and Photobiology|July 1, 1996

Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacyR K Pandey, A B Sumlin, S Constantine, et al.

Journal of Medicinal Chemistry|May 4, 2001

Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1'-alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicityG Zheng, W R Potter, S H Camacho, et al.

AIDS (London, England)|October 6, 1999

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcomaZ P Bernstein, B D Wilson, A R Oseroff, et al.

Cancer Research|February 17, 2000

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateB W Henderson, T M Busch, L A Vaughan, et al.

Pageof 3